ACS/STEMI

7/12/2021, Dr. Phil Horwitz.

Non-Ischemic Cardiomyopathy

NICM Handout

HFpEF

<iframe src=”https://uicapture.hosted.panopto.com/Panopto/Pages/Embed.aspx?id=1fc43219-f153-4bb6-98ad-ad2c012f223a&autoplay=false&offerviewer=true&showtitle=true&showbrand=false&start=0&interactivity=all” height=”405″ width=”720″ style=”border: 1px solid #464646;” allowfullscreen allow=”autoplay”></iframe> R2 talk – Understanding HFpEF Dr. Abdelhamid   1.     Definition a.     Heart failure in general is when the heart’s oxygen delivery is not meeting the body’s oxygen demand and if it does meet it, it is with high chamber filling pressures b.     Heart failure with […]

Cardiogenic shock and hemodynamics

<iframe src=”https://uicapture.hosted.panopto.com/Panopto/Pages/Embed.aspx?id=8c07af5c-7b46-4fb4-a405-ad17012b705b&autoplay=false&offerviewer=true&showtitle=true&showbrand=false&start=0&interactivity=all” height=”405″ width=”720″ style=”border: 1px solid #464646;” allowfullscreen allow=”autoplay”></iframe> Talk by Dr. Jared Robl, PGY-2 Hemodynamics Review: * Mean Arterial Pressure = Cardiac Output x Systemic Vascular Resistance * Cardiac Output (L/min) = heart rate (bpm) x SV (ml) * Determinants of Stroke Volume are o 1) Preload * the end diastolic volume (not […]

Atrial Fibrillation Management

Dr. Troy Rhodes September 25th, 2020

Atrial Fibrillation

Overview of Atrial FibrillationMichael C. Giudici, MD, FACC, FACP, FHRS Atrial fibrillation affects  more than 3 million in the US with projected incidence of 7.56 million by 2050. It is an indipendent predictor for mortality, increases risk for thromboembolic events and reduces quality of life. Atrial fibrillation is caused by atrial electrophysical abnormalities, structural abnormalities […]

Cardiomyopathies

Internal Medicine Grand Rounds September 12, 2019 Cardiac MRI and the CardiomyopathiesMahi Ashwath, MD

CPC – STEMI

Internal Medicine Grand Rounds Clinical Pathology Conference October 31, 2019CPC: Mechanical complications of STEMISidakpal Panaich, MBBS, Jon Thomason, MD (Molecular Genetics Fellow)

Aortic Valve Disease

Dr. Lindower February 2017 R2 Talk: Dr. Emily Nguyen, MD, PhD Mentor: Dr. Milena Gebska, MD, PhD <iframe src=”https://uicapture.hosted.panopto.com/Panopto/Pages/Embed.aspx?id=8a80441f-911c-44f4-b55e-ad0f012c1fa0&autoplay=false&offerviewer=true&showtitle=true&showbrand=false&start=0&interactivity=all” height=”405″ width=”720″ style=”border: 1px solid #464646;” allowfullscreen allow=”autoplay”></iframe> Aortic Stenosis Definition: Valvular aortic stenosis is a progressive disease in which the end stage is characterized by obstruction of left ventricular outflow, resulting in inadequate cardiac output, […]

Myopericarditis

Dr. Muellerleile March 2017